Developments in early-stage NSCLC: Advances in radiotherapy

Annals of Oncology

Volumn 23, Issue SUPPL. 10, 2012, Pages

  Verstegen, N E ^a   Lagerwaard, F J ^a   Senan, S ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Non small cell lung cancer; SABR; Stereotactic radiotherapy

Indexed keywords

ABLATION THERAPY; ADVERSE OUTCOME; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; GERIATRIC PATIENT; HIGH RISK PATIENT; HUMAN; LUNG NON SMALL CELL CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RIB FRACTURE; RISK ASSESSMENT; RISK FACTOR; SALVAGE THERAPY; SKIN MANIFESTATION; STEREOTACTIC TREATMENT; SURVIVAL TIME; THORAX PAIN; TREATMENT FAILURE;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; RADIATION DOSAGE; RADIOSURGERY;

EID: 84866762807     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds301     Document Type: Article

References (46)

1. van der Drift MA, Karim-Kos HE, Siesling S et al. Progress in standard of care therapy and modest survival benefits in the treatment of non-small cell lung cancer patients in the Netherlands in the last 20 years. J Thorac Oncol 2012: 7: 291-298.
2. Bach PB, Cramer LD, Warren JL et al. Racial differences in the treatment of early-stage lung cancer. N Engl J Med 1999; 341: 1198-1205.
3. Palma D, Senan S. Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer. Curr Opin Oncol 2011; 23: 133-139.
4. Edwards BK, Howe HL, Ries LA et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002; 94: 2766-2792.
5. Janssen-Heijnen ML, Maas HA, Houterman S et al. Comorbidity in older surgical cancer patients: influence on patient care and outcome. Eur J Cancer 2007; 43: 2179-2193.
6. Finlayson E, Fan Z, Birkmeyer JD. Outcomes in octogenarians undergoing high-risk cancer operation: a national study. J Am Coll Surg 2007; 205: 729-734.
7. Wisnivesky JP, Halm E, Bonomi M et al. Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer. Am J Respir Crit Care Med 2010; 81: 264-269.
8. Detterbeck FC, Gibson CJ. Turning gray: the natural history of lung cancer over time. J Thorac Oncol 2008; 3: 781-792.
9. Haasbeek CJ, Slotman BJ, Senan S. Radiotherapy for lung cancer: clinical impact of recent technical advances. Lung Cancer 2009; 64: 1-8.
10. Chi A, Tomé WA, Fowler J et al. Stereotactic body radiation therapy in non-smallcell lung cancer: linking radiobiological modeling and clinical outcome. Am J Clin Oncol 2011; 34: 432-441.
11. Park CH, Bonomi M, Cesaretti J et al. Effect of radiotherapy planning complexity on survival of elderly patients with unresected localized lung cancer. Int J Radiat Oncol Biol Phys 2011; 81: 706-711.
12. Timmerman R, Paulus R, Galvin J et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303: 1070-1076.
13. Baumann P, Nyman J, Hoyer M et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009; 27: 3290-3296.
14. Verstegen NE, Lagerwaard FJ, Haasbeek CJ et al. Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease. Radiother Oncol 2011; 101: 250-254.
15. Haasbeek CJA, Palma DA, Visser O et al. Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands. Ann Oncol 2012, May 2 [epub ahead of print], doi: 10.1093/annonc/mds081.
16. Baldwin DR, White B, Schmidt-Hansen M et al. Guideline Development Group. Diagnosis and treatment of lung cancer: summary of updated NICE guidance. Br Med J 2011; 342: d2110.
17. Palma D, Visser O, Lagerwaard FJ et al. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol 2010; 28: 5153-5159.
18. Hurkmans CW, Cuijpers JP, Lagerwaard FJ et al. Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol 2009; 4: 1.
19. Underberg RW, Lagerwaard FJ, Cuijpers JP et al. Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer. Int J Radiat Oncol Biol Phys 2004; 60: 1283-1290.
20. Harley DP, Krimsky WS, Sarkar S et al. Fiducial marker placement using endobronchial ultrasound and navigational bronchoscopy for stereotactic radiosurgery: an alternative strategy. Ann Thorac Surg 2010; 89: 368-373.
21. Liu HH, Balter P, Tutt T et al. Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys 2007; 68: 531-540.
22. Guckenberger M, Krieger T, Richter A et al. Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy. Radiother Oncol 2009; 91: 288-295.
23. Senan S, Palma D. Stereotactic lung radiotherapy: do we need fiducial markers? Ann Thorac Surg 2011; 91: 335-336.
24. Verbakel WF, Senan S, Cuijpers JP et al. Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs. Radiother Oncol 2009; 93: 122-124.
25. Ong CL, Verbakel WF, Dahele M et al. Fast arc delivery for stereotactic body radiotherapy of vertebral and lung tumors. Int J Radiat Oncol Biol Phys 2012; 83: 137-143.
26. Lagerwaard FJ, Haasbeek CJ, Smit EF et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008; 70: 685-692.
27. Bongers EM, Haasbeek CJ, Lagerwaard FJ et al. Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer. J Thorac Oncol 2011; 6: 2052-2057.
28. Guckenberger M, Kestin LL, Hope AJ et al. Is there a lower limit of pretreatment pulmonary function for safe and effective stereotactic body radiotherapy for earlystage non-small cell lung cancer? J Thorac Oncol 2012; 7: 542-551.
29. Palma D, Lagerwaard F, Rodrigues G. Curative treatment of stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys 2012; 82: 1149-1156.
30. van der Voort van Zyp NC, Prévost JB, van der Holt B et al. Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2010; 77: 31-37.
31. Lagerwaard FJ, Aaronson NK, Gundy CM et al. Patient-reported quality of life after stereotactic ablative radiotherapy for early stage lung cancer. J Thorac Oncol 2012; 7: 1148-1158.
32. Schulte T, Schniewind B, Walter J et al. Age-related impairment of quality of life after lung resection for non-small cell lung cancer. Lung Cancer 2010; 68: 115-120.
33. Balduyck B, Hendriks J, Sardari Nia P et al. Quality of life after lung cancer surgery: a review. Minerva Chir 2009; 64: 655-663.
34. Timmerman R, McGarry R, Yiannoutsos C et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24: 4833-4839.
35. Haasbeek CJ, Lagerwaard FJ, Slotman BJ et al. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. J Thorac Oncol 2011; 6: 2036-2043.
36. Nuyttens JJ, van der Voort van Zyp NC, Praag J et al. Outcome of fourdimensional stereotactic radiotherapy for centrally located lung tumors. Radiother Oncol 2012; 102: 383-387.
37. Murai T, Shibamoto Y, Baba F et al. Progression of non-small-cell lung cancer during the interval before stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2012; 82: 463-467.
38. Gazdar AF, Minna JD. Multifocal lung cancers-clonality vs field cancerization and does it matter? J Natl Cancer Inst 2009; 101: 541-543.
39. Flieder DB, Vazquez M, Carter D et al. Pathologic findings of lung tumors diagnosed on baseline CT screening. Am J Surg Pathol 2006; 30: 606-613.
40. Haasbeek CJ, Lagerwaard FJ, de Jaeger K et al. Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy. Cancer 2009; 115: 587-594.
41. Dahele M, Palma D, Lagerwaard F et al. Radiological changes after stereotactic radiotherapy for stage I lung cancer. J Thorac Oncol 2011; 6: 1221-1228.
42. Matsuo Y, Nakamoto Y, Nagata Y et al. Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer. Radiother Oncol 2010; 97: 200-204.
43. Huang K, Dahele M, Senan S et al. Radiographic changes after lung stereotactic ablative radiotherapy (SABR) - can we distinguish recurrence from fibrosis? A systematic review of the literature. Radiother Oncol 2012; 102: 335-342.
44. Onishi H, Shirato H, Nagata Y et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 2011; 81: 1352-1358.
45. Lagerwaard FJ, Verstegen NE, Haasbeek CJ et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011; 83: 348-353.
46. Chen F, Matsuo Y, Yoshizawa A et al. Salvage lung resection for non-small cell lung cancer after stereotactic body radiotherapy in initially operable patients. J Thorac Oncol 2010; 5: 1999-2002.